More HCPs Opting for Digital Technology During Clinical Trials

Would you be surprised to learn that sixty-four percent of clinical trial executives have used digital technology in their research and ninety-seventy plan on doing so? Perhaps not.The question may no longer be, 'how comfortable health care professionals feel with using technological advancements to better assist with their research and development' but where are we headed and how will the demand for innovation impact big pharma?According to a newsurvey conducted by Validic, of 166 executives at pharma and biotech companies, contract research organizations, and others in the clinical trial space."The use of digital health technologies and patient-generated health data is becoming a proven necessity to the operational efficiency and patient-centricity of the pharmaceutical industry," said Validic CEO and Co-Founder Drew Schiller who spoke at theDPharm Disruptive Innovations US in Boston. "This remotely-collected data has the potential to reduce patient burden allowing for more passive engagement and data collection, while also improving the accuracy of data patients contribute during and after trials," Schiller adds.The survey also found that 33 percent of respondents had used wearable activity trackers, 36 percent had used sensors, 45 percent had used in-home clinical grade medical diagnostic devices and 47 percent had used apps. And of these apps and devices, more than half of the respondents indicated that they planned on using them in the future.As part of their study, Val...

Source: ePharma Summit - October 20, 2016 Category: Pharmaceuticals Tags: Apps Big Pharma clinical trials Digital Health digital technology eHealth mhealth Mobile Apps mobile health Source Type: blogs